As of 2026-05-27, the Relative Valuation of Avecho Biotechnology Ltd (AVE.AX) is (0.02) AUD. This relative valuation is based on P/E multiples. With the latest stock price at 0.01 AUD, the upside of Avecho Biotechnology Ltd based on Relative Valuation is -277.1%.
The range of the Relative Valuation is (0.03) - (0.02) AUD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 21.7x - 27.3x | 25.0x |
| Forward P/E multiples | 12.3x - 17.6x | 13.3x |
| Fair Price | (0.03) - (0.02) | (0.02) |
| Upside | -300.9% - -263.0% | -277.1% |
| Date | P/E |
| 2026-05-25 | -9.98 |
| 2026-05-22 | -9.98 |
| 2026-05-21 | -10.40 |
| 2026-05-20 | -10.40 |
| 2026-05-19 | -10.81 |
| 2026-05-18 | -10.81 |
| 2026-05-15 | -10.81 |
| 2026-05-14 | -11.23 |
| 2026-05-13 | -10.81 |
| 2026-05-12 | -9.98 |
| 2026-05-11 | -10.81 |
| 2026-05-08 | -10.81 |
| 2026-05-07 | -9.98 |
| 2026-05-06 | -9.98 |
| 2026-05-05 | -9.98 |
| 2026-05-04 | -9.98 |
| 2026-05-01 | -9.98 |
| 2026-04-30 | -9.15 |
| 2026-04-29 | -9.98 |
| 2026-04-28 | -8.73 |
| 2026-04-27 | -9.15 |
| 2026-04-24 | -9.15 |
| 2026-04-23 | -8.73 |
| 2026-04-22 | -7.49 |
| 2026-04-20 | -7.90 |
| 2026-04-17 | -7.49 |
| 2026-04-16 | -7.49 |
| 2026-04-15 | -7.49 |
| 2026-04-14 | -7.49 |
| 2026-04-13 | -7.49 |
| 2026-04-10 | -7.49 |
| 2026-04-09 | -7.49 |
| 2026-04-08 | -7.90 |
| 2026-04-07 | -7.49 |
| 2026-04-02 | -7.49 |
| 2026-04-01 | -7.07 |
| 2026-03-31 | -6.65 |
| 2026-03-30 | -7.07 |
| 2026-03-27 | -7.49 |
| 2026-03-26 | -7.49 |
| 2026-03-25 | -7.90 |
| 2026-03-24 | -6.65 |
| 2026-03-23 | -6.65 |
| 2026-03-20 | -7.49 |
| 2026-03-19 | -7.49 |
| 2026-03-18 | -7.90 |
| 2026-03-17 | -7.90 |
| 2026-03-16 | -9.15 |
| 2026-03-13 | -8.32 |
| 2026-03-12 | -8.73 |